Income Statement
GE HEALTHCARE TECHNOLOGIES INC.
GEHC
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
20,625.00 | 19,672.00 | 19,552.00 |
|
Cost of Revenue
|
8,942.00 | 8,271.00 | 8,465.00 |
|
Gross Profit
|
8,248.00 | 8,205.00 | 7,922.00 |
|
Operating Expenses
|
5,485.00 | 5,580.00 | 5,487.00 |
|
Research & Development
|
1,260.00 | 1,311.00 | 1,205.00 |
|
Selling, General & Administrative
|
4,225.00 | 4,269.00 | 4,282.00 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
2,763.00 | 2,625.00 | 2,435.00 |
|
Non-Operating Income
|
-5.00 | 44.00 | 74.00 |
|
Interest Income
|
- | - | - |
|
Interest Expense
|
- | - | - |
|
Other Non-Op Income / Expense
|
3.00 | 10.00 | 11.00 |
|
Income Before Tax
|
2,768.00 | 2,581.00 | 2,361.00 |
|
Income Tax Expense
|
684.00 | 588.00 | 793.00 |
|
Non-Controlling Interest
|
70.00 | 57.00 | 46.00 |
|
Net Income
|
2,084.00 | 1,993.00 | 1,568.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
2,763.00 | 2,625.00 | 2,435.00 |
|
Earnings Per Share (Basic)
|
4.56 | 4.37 | 3.05 |
|
Diluted EPS
|
4.55 | 4.34 | 3.03 |
|
Weighted Average Shares
|
456.00 | 456.00 | 455.00 |
|
Diluted Weighted Avg Shares
|
458.00 | 459.00 | 458.00 |
|
Comprehensive Income
|
2,074.00 | 1,306.00 | 755.00 |